266 related articles for article (PubMed ID: 35763080)
1. Ethnic disparities attributed to the manifestation in and response to type 2 diabetes: insights from metabolomics.
Vasishta S; Ganesh K; Umakanth S; Joshi MB
Metabolomics; 2022 Jun; 18(7):45. PubMed ID: 35763080
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies.
Jin Q; Ma RCW
Cells; 2021 Oct; 10(11):. PubMed ID: 34831057
[TBL] [Abstract][Full Text] [Related]
4. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.
de Mello VD; Paananen J; Lindström J; Lankinen MA; Shi L; Kuusisto J; Pihlajamäki J; Auriola S; Lehtonen M; Rolandsson O; Bergdahl IA; Nordin E; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Landberg R; Eriksson JG; Tuomilehto J; Hanhineva K; Uusitupa M
Sci Rep; 2017 Apr; 7():46337. PubMed ID: 28397877
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of Type 1 and Type 2 Diabetes.
Arneth B; Arneth R; Shams M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
[TBL] [Abstract][Full Text] [Related]
6. Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts.
Bel Lassen P; Attaye I; Adriouch S; Nicolaou M; Aron-Wisnewsky J; Nielsen T; Chakaroun R; Le Chatelier E; Forslund S; Belda E; Bork P; Bäckhed F; Stumvoll M; Pedersen O; Herrema H; Groen AK; Pinto-Sietsma SJ; Zwinderman AH; Nieuwdorp M; Clement K; On Behalf Of Metacardis Consortium
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579043
[TBL] [Abstract][Full Text] [Related]
7. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S; Tripathi P
J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
[TBL] [Abstract][Full Text] [Related]
9. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.
Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P
J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.
Li J; Morrow C; Barnes S; Wilson L; Womack ED; McLain A; Yarar-Fisher C
Arch Phys Med Rehabil; 2022 Apr; 103(4):702-710. PubMed ID: 34126067
[TBL] [Abstract][Full Text] [Related]
11. Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes.
Knebel B; Strassburger K; Szendroedi J; Kotzka J; Scheer M; Nowotny B; Müssig K; Lehr S; Pacini G; Finner H; Klüppelholz B; Giani G; Al-Hasani H; Roden M;
J Clin Endocrinol Metab; 2016 May; 101(5):2130-40. PubMed ID: 26829444
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application.
Klein MS; Shearer J
J Diabetes Res; 2016; 2016():3898502. PubMed ID: 26636104
[TBL] [Abstract][Full Text] [Related]
13. Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites.
Fujisaka S; Avila-Pacheco J; Soto M; Kostic A; Dreyfuss JM; Pan H; Ussar S; Altindis E; Li N; Bry L; Clish CB; Kahn CR
Cell Rep; 2018 Mar; 22(11):3072-3086. PubMed ID: 29539432
[TBL] [Abstract][Full Text] [Related]
14. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
[TBL] [Abstract][Full Text] [Related]
15. Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies.
Jiang Z; Sun TY; He Y; Gou W; Zuo LS; Fu Y; Miao Z; Shuai M; Xu F; Xiao C; Liang Y; Wang J; Xu Y; Jing LP; Ling W; Zhou H; Chen YM; Zheng JS
BMC Med; 2020 Dec; 18(1):371. PubMed ID: 33267887
[TBL] [Abstract][Full Text] [Related]
16. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
Shao J; Liu Y; Wang H; Luo Y; Chen L
Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics and Lipidomics Profiling Reveals Hypocholesterolemic and Hypolipidemic Effects of Arabinoxylan on Type 2 Diabetic Rats.
Nie Q; Xing M; Chen H; Hu J; Nie S
J Agric Food Chem; 2019 Sep; 67(38):10614-10623. PubMed ID: 31483658
[TBL] [Abstract][Full Text] [Related]
19. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L; Orho-Melander M
Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
